5‐HT2C receptor agonists attenuate pain‐related behaviour in a rat model of trigeminal neuropathic pain

European Journal of Pain - Tập 14 - Trang 999-1006 - 2010
Kunihiro Nakai1, Aya Nakae2, Sosuke Oba1, Takashi Mashimo2, Koichi Ueda1
1Department of Plastic & Reconstructive Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan
2Department of Anesthesiology & Intensive Care Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan

Tóm tắt

AbstractPeripheral branches of the trigeminal nerve may be damaged during maxillofacial injury or surgical procedures and trigeminal trauma may induce severe pain that is very challenging to treat. Chronic constriction injury to the infraorbital nerve (ION‐CCI) by loose ligatures has proven a useful model for some types of trigeminal neuropathic pain disorder. Using ION‐CCI rats, we examined the antiallodynic effects of intrathecally administered agents which are selective for 5‐HT2C receptors. Allodynia was evaluated by applying von Frey filaments to skin innervated by the injured ION. Dose‐dependent antiallodynic effects followed administration of three 5‐HT2C receptor agonists, 6‐chloro‐2‐(1‐piperazinyl)‐pyrazine (MK212: 10, 30, and 100 μg); (S)‐2‐(chloro‐5‐fluoro‐indol‐l‐yl)‐1‐methyamine fumarate (RO 60‐0175: 10, 30, and 100 μg); (AaR)‐8,9‐dichloro‐2,3,4,4a‐tetrahydro‐1H‐pyrazino[1,2‐a]quinoxalin‐5(6H)‐one (WAY‐161503: 10, 30, and 100 μg). ED50 values for antiallodynic effects of MK212, RO 60‐0175, and WAY‐161503 were 39.62, 46.67, and 51.22 μg, respectively. Intrathecal administration of the 5‐HT2C receptor antagonist, 8‐[5‐2,4‐dimethoxy‐5‐(4‐trifluoromethylphenylsulphonamido)phenyl‐5‐oxopentyl]‐1,3,8‐triazaspiro[4,5]decane‐2,4‐dione (RS‐102221: 30 μg) did not alter the mechanical threshold. Intrathecal pretreatment with RS‐102221 (10 and 30 μg) reduced the antiallodynic effects of the highest dose of 5‐HT2C agonists. These results indicated that, in this rat model, the 5‐HT2C receptor plays a role in spinal inhibition of trigeminal neuropathic pain.

Tài liệu tham khảo

10.1016/S0893-133X(98)00046-3 10.1523/JNEUROSCI.11-07-01881.1991 10.1016/S0304-3940(98)00099-8 10.1016/0304-3940(82)90297-X 10.1016/0304-3959(88)90209-6 10.1016/S0304-3940(00)01681-5 10.1016/S0028-3908(97)00049-X 10.1038/sj.bjp.0705328 10.1038/sj.bjp.0706935 10.1038/387303a0 10.1046/j.1471-4159.2002.00811.x 10.1016/S0304-3959(99)00126-8 10.1016/S0304-3959(01)00305-0 10.1016/0006-8993(88)90089-3 10.1016/j.ejpain.2007.08.008 10.1016/S0028-3908(02)00119-3 Conn P.J., 1987, Relative efficacies of piperazines at the phosphoinositide hydrolysis‐linked serotonergic (5‐HT‐2 and 5‐HT‐1C) receptors, J Pharmacol Exp Ther, 424, 552 10.1016/S0014-2999(02)02640-7 10.1146/annurev.ne.14.030191.001251 10.1124/pr.59.07103 10.1016/S0169-328X(01)00049-3 10.1016/0024-3205(96)00230-5 10.1016/S0306-4522(01)00510-3 10.1016/j.ejphar.2004.01.036 Grottick A.J., 2000, Studies to Investigate the Role of 5‐HT2C receptors on cocaine‐ and food‐maintained behavior, J Pharmacol Exp Ther, 295, 1183 10.1046/j.1471-4159.1999.731711.x 10.1016/j.neuroscience.2006.11.004 10.1016/S0304-3959(98)00172-9 10.1016/j.ejphar.2004.08.048 10.1016/S0901-5027(87)80160-1 10.1038/sj.bjp.0704979 10.1007/BF00839537 10.1007/BF00791140 10.1523/JNEUROSCI.2552-08.2008 10.1016/j.neuropharm.2008.10.005 10.1016/j.pain.2004.06.010 10.1016/S0278-2391(98)90003-9 Martin J.R., 1998, 5‐HT2C receptor agonists: pharmacological characteristics and therapeutic potential, J Paramacol Exp Ther, 286, 913 10.1016/S0165-6147(00)01688-6 10.1126/science.174.4016.1351 10.1073/pnas.86.17.6793 10.1523/JNEUROSCI.22-15-06724.2002 10.1097/00000542-199406000-00022 10.1016/j.neures.2007.10.004 10.1111/j.1460-9568.2008.06205.x 10.1016/S0893-133X(00)00223-2 10.1016/j.ejphar.2007.03.029 10.1016/j.pain.2003.12.019 10.1016/S0006-8993(02)02288-6 10.1016/j.pain.2005.12.023 10.1016/0169-328X(94)90223-2 10.1111/j.1476-5381.2009.00406.x 10.1016/j.joms.2004.05.212 10.1016/j.brainres.2005.12.052 10.1213/01.ANE.0000050560.15341.A8 10.1016/0014-2999(92)90817-N 10.1016/0166-4328(96)00072-1 10.1016/S1010-5182(99)80019-5 10.1016/j.tips.2007.10.009 10.1016/j.ejphar.2003.11.028 10.1227/00006123-198412000-00031 10.1097/00002826-198403000-00003 10.1523/JNEUROSCI.23-02-00708.2003 10.1523/JNEUROSCI.14-05-02708.1994 10.1002/cne.903570304 10.1523/JNEUROSCI.16-08-02605.1996 10.1016/0031-9384(76)90029-9 Yaksh T.L., 1995, Reversal of nerve ligation‐induced allodynia by spinal alpha‐2 adrenoceptor agonists, J Pharmacol Exp Ther, 272, 207 10.1016/0014-2999(85)90474-1 10.1016/0014-2999(80)90154-5 10.1016/0304-3959(83)90201-4
Thông tin
Thông tin xuất bản

European Journal of Pain

Tập 14

999-1006

Thông tin tác giả